SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

FDA registers Aptar sites for extractables testing services

19-Apr-2011
Last updated the 19-Apr-2011 at 09:12 GMT

Aptar Pharma is providing extractables measurement services after registering two of its sites as contract testing laboratories with the FDA.

Identification and quantification of device extractables and leachables can now be outsourced to Aptar. The service is being offered after Aptar registered sites in Le Vaudreuil and Val-de-Reuil, France as contract testing laboratories with the US Food and Drug Administration (FDA).

A number of pharmaceutical and biotechnology companies working with Aptar Pharma drug delivery devices have expressed a requirement to use Aptar Pharma extractables testing for batch release of their drug products”, said Aptar.

On demand Supplier Webinars

Bioavailability market dynamics
William Reed Business Media
A brief history of bioavailability
William Reed Business Media
All supplier webinars